The proposed conference, titled "Advances in Melanoma: From Biology to Therapy," will be held from September 20-23, 2014 at the Loews Philadelphia, Philadelphia, PA. This special conference will address the unique issues and challenges in investigating and effectively treating melanoma. The goal of this conference is to bring together the top basic, translational, and clinical researchers in the field to discuss how basic research findings can be translated effectively into novel treatment options in the clinic. Scientific sessions will consist of seven presentations in major session (four hours) and three presentations in minor (two hours) sessions from expert researchers. Each presentation from expert researchers will be 20-25 minute presentations long. Additionally, to encourage young investigators one to two proffered short talk 15-20 minute will be incorporated in each session with ample time for discussion. Conference will start with presentations covering the advances in genetics, epigenetics, pathogenesis of melanoma biology, leading the discussion into principles of response and resistance to therapy-currently a major problem, concluding the discussion on emerging new strategies of using combination therapy. A special one-hour panel discussion will focus on challenges and opportunities in the melanoma research. Poster sessions will be held to allow investigators to present and discuss their latest research in an informal setting. This conference will appeal to investigators focused on the basic, translational, and clinical aspects of melanoma and will foster collaborative interdisciplinary interactions to stimulate the development of new research and clinical practices. It is expected that this new conference will provide a unique forum for discussions that will further the basic, translational, and clinical goals of the field.

Public Health Relevance

Melanoma is a deadliest form of skin cancer with no effective treatment available for the advanced disease. There is an urgent need to discuss latest understanding of the melanoma pathogenesis to identify novel strategies for better treatment and to overcome acquired drug resistance. At this conference, a wide range of basic, translational, and physicians scientists will assemble to present their recent findings, to foster collaborative interdisciplinary interactions with their peers and to help stimulate the development of novel treatment options.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Conference (R13)
Project #
1R13CA189528-01
Application #
8785875
Study Section
Special Emphasis Panel (ZCA1-PCRB-G (M2))
Program Officer
Duglas-Tabor, Yvonne
Project Start
2014-08-06
Project End
2015-07-31
Budget Start
2014-08-06
Budget End
2015-07-31
Support Year
1
Fiscal Year
2014
Total Cost
$4,000
Indirect Cost
Name
American Association for Cancer Research
Department
Type
DUNS #
139203590
City
Philadelphia
State
PA
Country
United States
Zip Code
19106